Shout out to Ugur Uslu (Ugur Uslu, MD) from Penn Medicine for his efforts to recap #immuno -oncology research from #ASGCT23 . Thanks for being a SITC Member. Access the recap: ow.ly/qR9X50OuxTC

ASGCT submitted comments to #FDA on post-approval data collection for CGT products. The Society advocates for responsible advancement of the field & supports a flexible approach to clinical trial design, use of natural history studies & more asgct.org/advocacy/polic… #ASGCTadvocacy

If you’re one of my tweeps and attending ASGCT, I’d love to meet you IRL. Genome editing is the future, friends

Biotech "2020 2: This Time With Feeling" Mongoose Howard Crawford what about income? does SFN bring in more revenue than ASGCT? what about membership size? does this just reflect the size of the membership?

Going to LA for the ASGCT Conference — 10/10 would recommend!

Had the honor of moderating a great session today at ASGCT! Gt at way to end the meeting!! #ASGCT2023

Jikkyleaks 🐭 You'd think the asgct would be authoritative.

asgct.org/publications/n…

Wonderful article on prenatal gene therapy papers presented at the recent ASGCT, including by our group.

Happy to have represented SITC at ASGCT annual meeting last week!

Society for Immunotherapy of Cancer ASGCT
#ScienceTwitter #MedTwitter #oncology

Choosing between investing in $GOLD and $BTC can be hard.

You’ll hear lots of people tell you that Bitcoin is the new digital gold. So, here’s why Bitcoin is nothing like gold and why you shouldn’t replace Bitcoin with gold in your investment portfolio.

Ending the ASGCT poster sessions strong with more #FinkLab presentations! Come visit Dr. Katherine Lucot and learn about Rescuing Haploinsufficient Expression of ADNP in Human and Mouse Cell Lines using CRISPR Activation #ASGCT 23 #ASGCT

Finishing ASGCT poster sessions with #FinkLab graduate presenter JJ Waldo! Come visit poster number 1447 to learn about Non-evolved dCas9 Epigenetic Editors Targetting NGG PAM Sites are Required for Knockdown of HTT #ASGCT 23 #ASGCT

On my way to ASGCT! Make sure to join Jaquelyn Zoine and me tomorrow morning to watch the finalists from our 5-Minute Thesis Challenge present! #ASGCT23

Today U.S. FDA granted accelerated approval to #Elevidys , a #GeneTherapy to treat patients 4-5 years old with #Duchenne #MuscularDystrophy ( #DMD ).

Read more on our blog: bit.ly/3NI5deO

Learn how your support of the AACR helps its more than 54,000 members worldwide advance cancer research that is saving lives every day.

NatureSweet is now B Corp Certified! B Corporation is a certification recognizing companies for the highest standards of social and environmental performance, transparency and accountability. NatureSweet joins a community of 6,000+ committed to positive impact.

$BEAM's ASGCT abstract for Stargardt disease
The optimized vector was injected into mice with the mutation, resulting in ~50% photoreceptor and ~80% RPE cell editing. In macaques, base editing rates were ~50% in cones, ~25% in rods, and ~70% in RPE cells.

Exciting times ahead for the #ARVC field! Great presentation by RocketPharma in Late-Breaking Oral Session @ASGCT about our preclinical studies on gene therapy for #PKP2ARVC . Stay tuned/Tune in on Sunday for the talk of Mario Delmar at #HRS2023 for more details.. Marina Cerrone

Dr. Rayne Rouce received the Award for Excellence in Advancing Diversity, Equity & Inclusion from the American Society of Gene and Cell Therapy. One of three new awards from ASGCT to acknowledge individuals who have done exceptional work in the areas of service, DEI & mentorship.

Hey #asgct attendees - come check out the second nonviral oral abstract session of the meeting starting at 3:45 pm in Petree Hall C!

Excited to co-chair this session packed with nanoparticles, CRISPR, plasmid trafficking, and more - see you there.

#ASGCT2023 #ASGCT23

Gene therapy stands to change how we cure disease. Treating earlier will often be better—and the womb is as early as it gets.

my newest from WIRED after attending #ASGCT23

wired.com/story/gene-the…

Happening today ASGCT! Jasmine L. Carter, PhD is presenting her poster on CRISPR-Based Site-Directed RNA Editing in Patient iPSC-derived Neuronal Models of Genetically-Linked Intellectual Disabilities #ASGCT #ASGCT 23

John Kohler Eric Meller Jonathan E. Canuck, MD @CrucesJh Jikkyleaks 🐭 I guess the ASGCT is a bunch of conspiracy theorists

asgct.org/publications/n…

Visit SCGE at #ASGCT23 ! Meet with NIH Program staff, demo the SCGE Toolkit, and learn how SCGE researchers are accelerating the translation of genome editing technology into disease treatments. Find out more: scge.mcw.edu/asgct

#GenomeEditing #GeneTherapy
NIH Common Fund

Major themes at #ASGCT23 included the ongoing retargeting & de-immunizing of AAV subunit capsids, scaleup & manufacture of leading cell types, & methods to economize payload size or targeting precision of CRISPR variants. Explore more in our latest blog-> roosterbio.com/blog/roosterbi…

ASGCT 2023—Gene therapy is becoming medicine #genetherapy #celltherapy dlvr.it/Sqzjft